Frameless linac-based stereotactic radiosurgery (SRS) for brain metastases: analysis of patient repositioning using a mask fixation system and clinical outcomes

被引:52
|
作者
Minniti, Giuseppe [1 ,2 ]
Scaringi, Claudia [1 ]
Clarke, Enrico [1 ]
Valeriani, Maurizio [1 ]
Osti, Mattia [1 ]
Enrici, Riccardo Maurizi [1 ]
机构
[1] Univ Roma La Sapienza, St Andrea Hosp, Dept Radiat Oncol, Rome, Italy
[2] Neuromed Inst, Dept Neurosci, Pozzilli, IS, Italy
关键词
stereotactic radiosurgery; positioning reproducibility; isocenter verification; brain metastases; QUALITY-ASSURANCE; TARGET LOCALIZATION; RADIATION-THERAPY; ACCURACY; RADIOTHERAPY; EXPERIENCE; HEAD; RADIOSURGERY/RADIOTHERAPY; REPRODUCIBILITY; IMMOBILIZATION;
D O I
10.1186/1748-717X-6-158
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To assess the accuracy of patient repositioning and clinical outcomes of frameless stereotactic radiosurgery (SRS) for brain metastases using a stereotactic mask fixation system. Patients and Methods: One hundred two patients treated consecutively with frameless SRS as primary treatment at University of Rome Sapienza Sant'Andrea Hospital between October 2008 and April 2010 and followed prospectively were involved in the study. A commercial stereotactic mask fixation system (BrainLab) was used for patient immobilization. A computerized tomography (CT) scan obtained immediately before SRS was used to evaluate the accuracy of patient repositioning in the mask by comparing the isocenter position to the isocenter position established in the planning CT. Deviations of isocenter coordinates in each direction and 3D displacement were calculated. Overall survival, brain control, and local control were estimated using the Kaplan-Meier method calculated from the time of SRS. Results: The mean measured isocenter displacements were 0.12 mm (SD 0.35 mm) in the lateral direction, 0.2 mm (SD 0.4 mm) in the anteroposterior, and 0.4 mm (SD 0.6 mm) in craniocaudal direction. The maximum displacement of 2.1 mm was seen in craniocaudal direction. The mean 3D displacement was 0.5 mm (SD 0.7 mm), being maximum 2.9 mm. The median survival was 15.5 months, and 1-year and 2-year survival rates were 58% and 24%, respectively. Nine patients recurred locally after SRS, with 1-year and 2-year local control rates of 91% and 82%, respectively. Stable extracranial disease (P = 0.001) and KPS > 70 (P = 0.01) were independent predictors of survival. Conclusions: Frameless SRS is an effective treatment in the management of patients with brain metastases. The presented non-invasive mask-based fixation stereotactic system is associated with a high degree of patient repositioning accuracy; however, a careful evaluation is essential since occasional errors up to 3 mm may occur.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Single-Isocenter Linac-Based Radiosurgery for Brain Metastases with Coplanar Arcs: A Dosimetric and Clinical Analysis
    Faccenda, Valeria
    Panizza, Denis
    Pisoni, Valerio
    Trivellato, Sara
    Daniotti, Martina Camilla
    Bianchi, Sofia Paola
    De Ponti, Elena
    Arcangeli, Stefano
    CANCERS, 2023, 15 (18)
  • [32] Plan Quality Comparison of Gamma Knife and Linac-Based Stereotactic Radiosurgery in the Treatment of Multiple Brain Metastases
    Carter, J.
    Ding, Y.
    Vergalasova, I.
    Wang, X.
    Zhang, Y.
    Weiner, J.
    Yue, N.
    Nie, K.
    MEDICAL PHYSICS, 2019, 46 (06) : E652 - E652
  • [33] Results after LINAC-based stereotactic one-time radiation treatment (radiosurgery) of brain metastases
    Alheit, H.
    Koy, J.
    Winkler, C.
    Blank, H.
    Geyer, P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 55 - 55
  • [34] Clinical Predictors of Distant Brain Failure and Early Salvage Whole Brain Radiation Therapy After LINAC-Based Stereotactic Radiosurgery for Brain Metastases
    Press, R. H.
    Prabhu, R. S.
    Nickleach, D.
    Liu, Y.
    Shu, H.
    Curran, W. J.
    Crocker, I. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S330 - S331
  • [35] Clinical outcomes of benign brain tumors treated with single fraction LINAC-based stereotactic radiosurgery: Experience of a single institute
    Chew, Chia-Hui
    Chen, Jin-Cherng
    Hung, Shih-Kai
    Wu, Tsung-Hsien
    Lee, Moon-Sing
    Chiou, Wen-Yen
    Chen, Liang-Cheng
    Lin, Hon-Yi
    TZU CHI MEDICAL JOURNAL, 2022, 34 (04): : 462 - 472
  • [36] Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases
    Sim, Austin J.
    Ahmed, Kamran A.
    Keller, Andrew
    Figura, Nicholas B.
    Oliver, Daniel E.
    Sarangkasiri, Siriporn
    Robinson, Timothy J.
    Johnstone, Peter A. S.
    Yu, Hsiang-Hsuan Michael
    Naghavi, Arash O.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (05): : 356 - 361
  • [37] Probabilistic Approach to Plan Evaluation in Linac-Based Stereotactic Radiosurgery: A Patient Specific Uncertainty Analysis
    Park, P.
    Roper, J.
    Fox, T.
    Schreibmann, E.
    Elder, E.
    Tejani, M.
    Curran, W.
    Crocker, I.
    Dhabaan, A.
    MEDICAL PHYSICS, 2014, 41 (06) : 345 - 345
  • [38] Investigation of Dosimetric Outcomes for Arteriovenous Malformations with Linac-Based SRS vs. Non-invasive Stereotactic Radiosurgery Planning
    Garcia, B.
    Calugaru, E.
    Chitti, B.
    Delacruz, B.
    Goenka, A.
    Chang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E572 - E572
  • [39] Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases(vol 17, 213, 2022)
    Hirata, Masanori
    Yasui, Kazuaki
    Oota, Naofumi
    Ogawa, Hirofumi
    Onoe, Tsuyoshi
    Maki, Sayo
    Ito, Yusuke
    Hayashi, Kenji
    Asakura, Hirofumi
    Murayama, Shigeyuki
    Mitsuya, Koichi
    Deguchi, Shoichi
    Nakamura, Katsumasa
    Hayashi, Nakamasa
    Nishimura, Tetsuo
    Harada, Hideyuki
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [40] Automated Planning to Improve Linac-Based Stereotactic Radiosurgery Plan Quality in Patients with 4 up to 10 Brain Metastases
    Petoukhova, A.
    Snijder, R.
    Wiggenraad, R.
    de Boer-de Wit, L.
    Mudde-van der Wouden, I.
    Florijn, M.
    Zindler, J.
    van Santvoort, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E770 - E770